Overview
At BioHealth Innovations, we are at the forefront of biotech innovation, harnessing the power of genomics and personalized medicine to tackle chronic diseases. Our flagship product, GenuHeal, utilizes advanced algorithms to analyze genomic data, enabling tailored treatment plans for patients suffering from conditions like diabetes and autoimmune disorders. Since launching our initial prototype in 2025, we've conducted successful trials with a 95% patient satisfaction rate, demonstrating significant improvements in health outcomes. Currently, we are looking for a strategic partner willing to invest $2,700,000 to expand our R&D efforts and enhance manufacturing capabilities. The investment will help us transition from pilot to full-scale production and facilitate further clinical trials, allowing us to bring GenuHeal to a broader market. With the growing demand for personalized healthcare solutions and a total addressable market valued at $80 billion, this is a timely opportunity for both our company and potential investors. Our team consists of seasoned professionals from the biotech and healthcare industries, including experts in genomics, data science, and business operations. We…
Use of funds
The $2,700,000 investment will be allocated as follows:
- 40% for R&D to enhance our GenuHeal product.
- 30% for scaling manufacturing processes and equipment.
- 20% for marketing efforts to increase brand awareness and reach potential clients.
- 10% for hiring additional talent to support our growth in sales and operations.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.